The present invention is directed to prodrugs of certain
3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives that modulate the
activity of protein kinases ("PKs"). Pharmaceutical compositions
comprising these compounds, methods of treating diseases related to
abnormal PK activity utilizing pharmaceutical compositions comprising
these compounds and methods of preparing them are also disclosed.